Emergence of SARS-CoV-2 Variants in the World: How Could This Happen?

Overview

Journal Life (Basel)

Specialty Biology

Date 2022 Feb 25

PMID 35207482

Authors

Alfredo Parra-Lucares

Paula Segura

Veronica Rojas

Catalina Pumarino

Gustavo Saint-Pierre

Luis Toro

Affiliations

Soon will be listed here.

Abstract

The COVID-19 pandemic has had a significant global impact, with more than 280,000,000 people infected and 5,400,000 deaths. The use of personal protective equipment and the anti-SARS-CoV-2 vaccination campaigns have reduced infection and death rates worldwide. However, a recent increase in infection rates has been observed associated with the appearance of SARS-CoV-2 variants, including the more recently described lineage B.1.617.2 (Delta variant) and lineage B.1.1.529/BA.1 (Omicron variant). These new variants put the effectiveness of international vaccination at risk, with the appearance of new outbreaks of COVID-19 throughout the world. This emergence of new variants has been due to multiple predisposing factors, including molecular characteristics of the virus, geographic and environmental conditions, and the impact of social determinants of health that favor the genetic diversification of SARS-CoV-2. We present a literature review on the most recent information available on the emergence of new variants of SARS-CoV-2 in the world. We analyzed the biological, geographical, and sociocultural factors that favor the development of these variants. Finally, we evaluate the surveillance strategies for the early detection of new variants and prevent their distribution outside these regions.

Citing Articles

S6P mutation in Delta and Omicron variant spike protein significantly enhances the efficacy of mRNA COVID-19 vaccines.

Bong Y, Brown D, Chung E, Ananthaswamy N, Chen R, Lewoczko E Front Immunol. 2025; 15():1495561.

PMID: 39830514 PMC: 11739128. DOI: 10.3389/fimmu.2024.1495561.

The role of inflammatory gene polymorphisms in severe COVID-19: a review.

Yip J, Oo A, Ng Y, Chin K, Tan K, Chu J Virol J. 2024; 21(1):327.

PMID: 39707400 PMC: 11662554. DOI: 10.1186/s12985-024-02597-3.

An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity.

Chang-Rabley E, van Zelm M, Ricotta E, Edwards E Vaccines (Basel). 2024; 12(6).

PMID: 38932404 PMC: 11209597. DOI: 10.3390/vaccines12060675.

A Narrative Overview of Coronavirus Infection: Clinical Signs and Symptoms, Viral Entry and Replication, Treatment Modalities, and Management.

Chavda V, Yadav D, Parmar H, Brahmbhatt R, Patel B, Madhwani K Curr Top Med Chem. 2024; 24(21):1883-1916.

PMID: 38859776 DOI: 10.2174/0115680266296095240529114058.

Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis.

Jeong G, Hwang I, Lee W, Choi J, Yoon G, Kim H Exp Mol Med. 2024; 56(5):1221-1229.

PMID: 38816566 PMC: 11148094. DOI: 10.1038/s12276-024-01197-z.

References

Taylor L . Covid-19: Brazil's spiralling crisis is increasingly affecting young people. BMJ. 2021; 373:n879. DOI: 10.1136/bmj.n879. View

Rae M . Omicron: a failure to act with a global focus will continue the proliferation of new variants of covid-19. BMJ. 2021; 375:n3095. DOI: 10.1136/bmj.n3095. View

Mlcochova P, Kemp S, Dhar M, Papa G, Meng B, Ferreira I . SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature. 2021; 599(7883):114-119. PMC: 8566220. DOI: 10.1038/s41586-021-03944-y. View

Brandt E, Mersha T . Environmental Determinants of Coronavirus Disease 2019 (COVID-19). Curr Allergy Asthma Rep. 2021; 21(3):15. PMC: 7934813. DOI: 10.1007/s11882-021-00993-1. View

Raskin S . Genetics of COVID-19. J Pediatr (Rio J). 2020; 97(4):378-386. PMC: 7539923. DOI: 10.1016/j.jped.2020.09.002. View

Kim S, Bostwick W . Social Vulnerability and Racial Inequality in COVID-19 Deaths in Chicago. Health Educ Behav. 2020; 47(4):509-513. PMC: 8183499. DOI: 10.1177/1090198120929677. View

Juliano C, Castrucci B, Fraser M . COVID-19 and Public Health: Looking Back, Moving Forward. J Public Health Manag Pract. 2020; :S1-S4. DOI: 10.1097/PHH.0000000000001300. View

Wong A, Kohler J . Social capital and public health: responding to the COVID-19 pandemic. Global Health. 2020; 16(1):88. PMC: 7517063. DOI: 10.1186/s12992-020-00615-x. View

Muth D, Corman V, Roth H, Binger T, Dijkman R, Gottula L . Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission. Sci Rep. 2018; 8(1):15177. PMC: 6181990. DOI: 10.1038/s41598-018-33487-8. View

10.

Kaimann D, Tanneberg I . What containment strategy leads us through the pandemic crisis? An empirical analysis of the measures against the COVID-19 pandemic. PLoS One. 2021; 16(6):e0253237. PMC: 8216519. DOI: 10.1371/journal.pone.0253237. View

11.

Castillo A, Parra B, Tapia P, Lagos J, Arata L, Acevedo A . Geographical Distribution of Genetic Variants and Lineages of SARS-CoV-2 in Chile. Front Public Health. 2020; 8:562615. PMC: 7536338. DOI: 10.3389/fpubh.2020.562615. View

12.

Javanian M, Barary M, Ghebrehewet S, Koppolu V, Vasigala V, Ebrahimpour S . A brief review of influenza virus infection. J Med Virol. 2021; 93(8):4638-4646. DOI: 10.1002/jmv.26990. View

13.

Callaway E . The coronavirus is mutating - does it matter?. Nature. 2020; 585(7824):174-177. DOI: 10.1038/d41586-020-02544-6. View

14.

Petersen E, Ntoumi F, Hui D, Abubakar A, Kramer L, Obiero C . Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts. Int J Infect Dis. 2021; 114:268-272. PMC: 8634699. DOI: 10.1016/j.ijid.2021.11.040. View

15.

Edara V, Pinsky B, Suthar M, Lai L, Davis-Gardner M, Floyd K . Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants. N Engl J Med. 2021; 385(7):664-666. PMC: 8279090. DOI: 10.1056/NEJMc2107799. View

16.

Leffler C, Ing E, Lykins J, Hogan M, Mckeown C, Grzybowski A . Association of Country-wide Coronavirus Mortality with Demographics, Testing, Lockdowns, and Public Wearing of Masks. Am J Trop Med Hyg. 2020; 103(6):2400-2411. PMC: 7695060. DOI: 10.4269/ajtmh.20-1015. View

17.

Harvey W, Carabelli A, Jackson B, Gupta R, Thomson E, Harrison E . SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021; 19(7):409-424. PMC: 8167834. DOI: 10.1038/s41579-021-00573-0. View

18.

Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J . Detection of a SARS-CoV-2 variant of concern in South Africa. Nature. 2021; 592(7854):438-443. DOI: 10.1038/s41586-021-03402-9. View

19.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

20.

Fisman D, Tuite A . Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada. CMAJ. 2021; 193(42):E1619-E1625. PMC: 8562985. DOI: 10.1503/cmaj.211248. View